Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage
- PMID: 19003349
- PMCID: PMC3449942
- DOI: 10.1023/A:1008030407679
Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage
Abstract
Coagulation factors, amongst many other proteins, often require posttranslational endoproteolytic processing for maturation. Upon high yield expression of recombinant forms of these proteins, processing frequently becomes severely limiting, resulting in a hampered function of the protein. In this report, the human endoprotease Furin was used to achieve complete propeptide removal from recombinant von Willebrand Factor (rvWF) precursors in CHO cells. At expression beyond 200 ng rvWF/106 cells x day, processing became insufficient. Stable co- and overexpression of full length Furin resulted in complete precursor cleavage in cell clones expressing 2 mug rvWF/106 cells x day. Rather than occuring intracellularly, processing was found to be mediated by a naturally secreted form of rFurin, present in 100 fold higher concentrations than endogenous Furin and accumulating in the cell culture supernatant. Attempts to increase rFurin yield by amplification, in order to ensure complete rvWF precursor processing at expression rates beyond 2 mug rvWF/106 cells x day, failed. Truncation of the trans-membrane domain resulted in immediate secretion of rFurin and approximately 10 fold higher concentrations in the conditioned medium. In cases where these high rFurin concentrations are not sufficient to ensure complete processing, an in vitro downstream processing procedure has to be established. Secreted affinity epitope-tagged rFurin derivatives were constructed, the fate of which, at expression, was dependent on the size of the C-terminal truncation and the type of the heterologous epitope added. A suitable candidate was purified by a one step affinity procedure, and successfully used for in vitro processing. This allows complete proteolytic processing of large amounts of precursor molecules by comparably small quantities of rFurin. Complete precursor cleavage of a target protein at expression rates of up to approximately 200 ng, 2 mug, and 20 mug, as well as beyond 20 mug/106 cells x day can thus be anticipated to be accomplished by endogenous Furin, additional expression of full length rFurin, co-expression of truncated and hence secreted rFurin, and a protein-chemical in vitro procedure, respectively.
Similar articles
-
Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitro.Biotechnol Appl Biochem. 1996 Dec;24(3):257-67. Biotechnol Appl Biochem. 1996. PMID: 8969456
-
Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro.Thromb Res. 2000 Jan 15;97(2):51-67. doi: 10.1016/s0049-3848(99)00145-0. Thromb Res. 2000. PMID: 10688334
-
Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.J Biol Chem. 1992 Jul 15;267(20):14304-8. J Biol Chem. 1992. PMID: 1629222
-
Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases.Crit Rev Oncog. 1993;4(2):115-36. Crit Rev Oncog. 1993. PMID: 8420571 Review.
-
Structure and function of a recombinant von Willebrand factor drug candidate.Semin Thromb Hemost. 2010 Jul;36(5):510-21. doi: 10.1055/s-0030-1255445. Epub 2010 Jul 15. Semin Thromb Hemost. 2010. PMID: 20635317 Review.
Cited by
-
'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus.Biochem J. 2001 Mar 15;354(Pt 3):689-95. doi: 10.1042/0264-6021:3540689. Biochem J. 2001. PMID: 11237874 Free PMC article.
-
Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.PLoS One. 2017 Oct 12;12(10):e0185967. doi: 10.1371/journal.pone.0185967. eCollection 2017. PLoS One. 2017. PMID: 29023479 Free PMC article.
-
The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.Cells. 2020 Nov 23;9(11):2528. doi: 10.3390/cells9112528. Cells. 2020. PMID: 33238570 Free PMC article. Review.
-
Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.Acta Naturae. 2013 Jan;5(1):73-84. Acta Naturae. 2013. PMID: 23556132 Free PMC article.
-
Introduction to animal cell culture technology-past, present and future.Cytotechnology. 2006 Mar;50(1-3):1-7. doi: 10.1007/s10616-006-9009-4. Epub 2006 Aug 3. Cytotechnology. 2006. PMID: 19003067 Free PMC article. No abstract available.
References
-
- Creemers JWM (1994) Structural and functional characterization of the mammalian proprotein processing enzyme Furin. Ph.D. Thesis at the University of Leuven, Belgium.
-
- Creemers JWM, Siezen RJ, Roebroek AJM, Ayoubi TAY, Huylebroeck D, van de Ven WJM. Modulation of Furinmediated proprotein processing activity by site-directed mutagenesis. J. Biol. Chem. 1993;268:21826–21834. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources